[Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].
Cai
Jun
J
International Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
Wu
Qiang
Q
Fan
Li
L
Liu
Chang-Fu
CF
Wang
Zhi-Guo
ZG
Sun
Jing
J
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000800:Angioplasty, Balloon; D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D000077144:Clopidogrel; D003327:Coronary Disease / Q000628:therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000494:pharmacology / Q000627:therapeutic use; D000077402:Pantoprazole; D010974:Platelet Aggregation / Q000187:drug effects*; D011184:Postoperative Period; D054328:Proton Pump Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D000077402:Pantoprazole; D009853:Omeprazole; D013988:Ticlopidine; D001241:Aspirin